The emerging treatment of the medication represents a significant development in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects two pathways – GLP-1 and GIP – leading https://tirzepatide-peptide108560.blogsuperapp.com/42567340/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment